*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Ciba-Geigy/NNP Ltd./NNP ]
and/CC 
[ Chiron/NNP Corp./NNP ]
said/VBD 
[ they/PRP ]
do/VBP n't/RB plan/VB to/TO raise/VB 
[ their/PRP$ offer/NN ]
for/IN 
[ Canadian/JJ vaccine/NN maker/NN Connaught/NNP BioSciences/NNP Inc./NNP ]
,/, clearing/VBG 
[ the/DT way/NN ]
for/IN 
[ a/DT competing/JJ bid/NN ]
by/IN 
[ Institut/NNP Merieux/NNP S.A./NNP ]
of/IN 
[ France/NNP ]
./. 

======================================

[ Institut/NNP Merieux/NNP last/JJ week/NN ]
offered/VBD 
[ 37/CD Canadian/JJ dollars/NNS ]
 (/( 
[ US$/$ 31.47/CD ]
 )/) 
[ a/DT share/NN ]
,/, or/CC 
[ C$/$ 942/CD million/CD ]
,/, for/IN 
[ Connaught/NNP ]
,/, topping/VBG 
[ Ciba-Geigy/NNP 's/POS ]
and/CC 
[ Chiron/NNP 's/POS joint/JJ bid/NN ]
of/IN 
[ C$/$ 30/CD ]

[ a/DT share/NN ]
,/, or/CC 
[ C$/$ 866/CD million/CD ]
./. 

======================================

``/`` 
[ We/PRP ]
decided/VBD that/IN 
[ we/PRP ]
are/VBP n't/RB prepared/JJ to/TO get/VB involved/JJ in/IN 
[ a/DT bidding/NN war/NN ]
at/IN 
[ this/DT sort/NN ]
of/IN 
[ price/NN level/NN ]
,/, ''/'' said/VBD 
[ Richard/NNP Williams/NNP ]
,/, 
[ head/NN ]
of/IN 
[ business/NN development/NN ]
for/IN 
[ Ciba-Geigy/NNP ]
,/, 
[ a/DT major/JJ pharmaceutical/JJ concern/NN ]
based/VBN in/IN 
[ Basel/NNP ]
,/, 
[ Switzerland/NNP ]
./. 

``/`` At/IN 
[ the/DT price/NN level/NN ]

[ we/PRP ]
would/MD have/VB reached/VBD ,/, {/( 
[ Connaught/NNP ]
 }/) is/VBZ just/RB totally/RB overvalued/VBN|JJ ,/, ''/'' 
[ he/PRP ]
said/VBD ./. 

======================================

[ Investors/NNS ]

[ who/WP ]
expected/VBD 
[ Ciba-Geigy/NNP ]
and/CC 
[ California-based/JJ Chiron/NNP ]
to/TO respond/VB to/TO 
[ Merieux/NNP 's/POS bid/NN ]
with/IN 
[ a/DT higher/JJR offer/NN ]
,/, pushed/VBD up/RP 
[ the/DT price/NN ]
of/IN 
[ Connaught/NNP 's/POS stock/NN last/JJ week/NN ]
to/TO 
[ a/DT 52-week/JJ high/NN ]
of/IN 
[ C$/$ 37.875/CD ]

[ a/DT share/NN ]
./. 

In/IN 
[ Toronto/NNP Stock/NNP Exchange/NNP trading/NN yesterday/NN ]
,/, 
[ Connaught/NNP ]
closed/VBD at/IN 
[ C$/$ 35.75/CD ]
,/, down/RB 
[ $/$ 2.25/CD ]
./. 

======================================

``/`` 
[ No/DT one/NN ]
believed/VBD 
[ they/PRP ]
'd/MD walk/VB away/RB at/IN 
[ C$/$ 30/CD ]
,/, ''/'' said/VBD 
[ one/CD analyst/NN ]
,/, 
[ who/WP ]
requested/VBD 
[ anonymity/NN ]
./. 

======================================

[ Samuel/NNP Isaly/NNP ]
,/, 
[ an/DT analyst/NN ]
and/CC 
[ partner/NN ]
in/IN 
[ Mehta/NNP ]
&/CC 
[ Isaly/NNP ]
,/, 
[ a/DT New/NNP York-based/JJ  pharmaceutical/JJ industry/NN research/NN firm/NN ]
,/, said/VBD 
[ Ciba-Geigy/NNP ]
and/CC 
[ Chiron/NNP 's/POS $/$ 30-a-share/JJ offer/NN ]
--/: 
[ which/WDT ]

[ the/DT two/CD ]
did/VBD n't/RB withdraw/VB --/: still/RB could/MD succeed/VB if/IN 
[ the/DT Merieux/NNP bid/NN ]
ran/VBD into/IN 
[ insurmountable/JJ regulatory/JJ problems/NNS ]
,/, although/IN 
[ no/DT such/JJ problems/NNS ]
have/VBP surfaced/VBN so/RB far/RB ./. 

[ He/PRP ]
also/RB said/VBD 
[ the/DT decision/NN ]
by/IN 
[ Ciba-Geigy/NNP ]
and/CC 
[ Chiron/NNP ]
makes/VBZ 
[ it/PRP ]
easier/JJR for/IN 
[ any/DT new/JJ bidders/NNS ]
,/, 
[ who/WP ]
might/MD have/VB been/VBN reluctant/JJ to/TO participate/VB in/IN 
[ a/DT three-way/JJ bidding/NN war/NN ]
,/, to/TO emerge/VB ./. 

======================================

[ A/DT Connaught/NNP official/NN ]
said/VBD 
[ the/DT company/NN has/VBZ n't/RB ]
been/VBN contacted/VBN by/IN 
[ any/DT other/JJ possible/JJ bidders/NNS ]
./. 

[ He/PRP ]
declined/VBD 
[ further/JJ comment/NN ]
./. 

======================================

[ Ciba-Geigy/NNP 's/POS Mr./NNP Williams/NNP ]
would/MD n't/RB say/VB whether/IN 
[ the/DT partners/NNS ]
plan/VBP to/TO extend/VB 
[ their/PRP$ ]
offer/NN ,/, to/TO expire/VB 
[ Oct./NNP 17/CD ]
./. 

[ The/DT bid/NN ]
by/IN 
[ Merieux/NNP ]
,/, 
[ which/WDT ]
is/VBZ 
[ 50.1/CD %/NN ]
--/: owned/VBN by/IN 
[ Rhone-Poulenc/NNP S.A./NNP ]
,/, expires/VBZ 
[ Oct./NNP 26/CD ]
./. 

[ Mr./NNP Williams/NNP ]
said/VBD 
[ the/DT partners/NNS ]
will/MD begin/VB examining/VBG 
[ other/JJ ways/NNS ]
to/TO get/VB involved/JJ in/IN 
[ the/DT vaccine/NN industry/NN ]
,/, including/VBG 
[ other/JJ ]
,/, 
[ smaller/JJR acquisitions/NNS ]
,/, 
[ joint/JJ ventures/NNS ]
or/CC marketing/NN and/CC 
[ licensing/NN agreements/NNS ]
./. 
